Mabtas T 100mg Injection: Effective Treatment Solution

Mabtas T 100mg Injection

Description:

• Contains the active constituent rituximab.
• Belongs to the class of medications called anti-CD20 monoclonal antibodies.

Uses:

• Non-Hodgkin’s lymphoma (NHL)
• Chronic lymphocytic leukemia (CLL)
• Rheumatoid arthritis
• Granulomatosis with polyangiitis or microscopic polyangiitis
• Pemphigus vulgaris

Therapeutic Effects:

• Targets the antigen CD20 expressed on the cell surface of B-lymphocytes.
• Induces cell death in NHL and CLL.
• Blocks cell activation and growth and cause anticancer effects.
• Inhibits rheumatoid factor production, antigen presentation, T-cell activation, and proinflammatory cytokine production in rheumatoid arthritis.

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take.
• Certain medications may interact with Mabtas T 100mg injection and reduce its effectiveness by causing undesirable side effects.

Safety Advices:

• Do not take if you are allergic to rituximab or any other ingredients of this medicine.
• Do not take if you have a weak immune system or any severe active infection.
• Pregnancy and breastfeeding are not recommended when you are taking this injection.
• Consult your doctor if you have heart disease, heart failure, breathing problems, or any liver impairment before initiating the treatment.
• Stop consuming alcohol if you are taking this medicine.
• Caution is required while driving and operating machinery.

Storage:

• Store Mabtas T 100mg injection in the refrigerator (2°C to 8°C).
• Do not freeze.
• Keep the injection away from the reach of children and pets.

Administration:

• Should only be administered by a trained doctor or nurse.
• Before giving Mabtas T 100mg injection, you will be given other medications (pre-medication) to reduce the possible side effects.
• Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors.
• It will be given as an intravenous infusion, and you will be monitored carefully for any unwanted side effects.

Side Effects:

• Common: swelling in the face and body, diarrhea and nausea, itchy skin, anemia, muscle spasm, headache, urinary tract infection, fever, chills, and shivering, inflammation of nasal cavities, cough, sore throat, loss of hair.
• Serious: increased or decreased blood pressure, chest pain, hypersensitivity reactions, hepatitis B viral infection, memory loss, trouble thinking, difficulty in walking.

FAQs:

1. What are the special precautions I should be aware of before starting treatment with Mabtas T 100mg injection?

   • Inform your doctor about your pre-existing conditions (heart, kidney, liver, hepatitis B, or lung disease) and vaccination history. It is necessary to consult a doctor if you are taking medicines for blood pressure.

2. What are Mabtas T 100mg infusion-related reactions?

   • Infusion reactions occur during or within 24 hours after administering Mabtas T 100mg injection. The symptoms are fever, chills, cough, itchy skin, nausea, vomiting, flushing, increased heart rate, and discomfort in the throat. Inform your physician immediately if you face any infusion-related reaction.

3. What will be the most important thing to monitor during Mabtas T 100mg injection?

   • Your healthcare professional will monitor you carefully for unwanted side effects during the Mabtas T 100mg injection. You will be monitored for heart failure, increased blood pressure, or breathing failure.

4. Is weight gain a side effect of Mabtas T 100mg injection?

   • Weight gain has been reported in patients treated with Mabtas T 100mg injection for non-Hodgkin’s lymphoma.

5. Does Mabtas T 100mg injection suppress the immune system?

   • Yes, it can suppress the immune system, and the chances of catching an infection are high. Inform your doctor if you have a severe active infection before taking Mabtas T 100mg injection because it may cause drug-induced immunosuppression.

Fact Box:

• Molecule name: Rituximab
• Therapeutic class: Antineoplastics, DMARDs
• Pharmacological class: Anti-CD20 monoclonal antibodies
• Indications: Non-Hodgkin’s lymphoma, Chronic lymphocytic leukemia (CLL), Rheumatoid Arthritis, Granulomatosis with polyangiitis or microscopic polyangiitis, Pemphigus vulgaris

Tags: medical-injection, mabtas-brand, pain-relief, anti-inflammatory, 100mg-dose